Thursday, January 4, 2007

Horizon Therapeutics Raises $15M

Palo Alto-based Horizon Therapeutics said today that it has raised $15M in a Series B financing, led by Scale Venture Partners. Horizon, which is developing non-steroidal, anti-inflammatory ibuprofen. The round also included Sutter Hill Ventures and Pequot Ventures. Horizon also disclosed a Series A round worth $6M in October of 2005 from the same investors. More information »